Freedom Capital Downgrades TruBridge to Hold with $26.25 Price Target
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 24 2026
0mins
Should l Buy TBRG?
Freedom Capital analyst Gene Mannheimer downgraded TruBridge to Hold from Buy with a $26.25 price target after the company reached an agreement to be acquired by Inventurus Knowledge Solutions for $26.25 per share in cash.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TBRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TBRG
Wall Street analysts forecast TBRG stock price to fall
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 25.750
Low
21.00
Averages
22.00
High
23.00
Current: 25.750
Low
21.00
Averages
22.00
High
23.00
About TBRG
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ:TBRG) for allegedly issuing materially misleading business information, which may entitle investors to compensation without any out-of-pocket fees.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to file the Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, which could undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns over the company's financial transparency and potential investor losses.
- Legal Action Preparation: Rosen Law Firm is preparing a class action to recover investor losses, emphasizing the importance of selecting qualified counsel with a successful track record to effectively protect investors' rights.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating Organon & Co. (NYSE:OGN) regarding its sale to Sun Pharmaceutical Industries Limited at $14.00 per share, which may involve breaches of shareholder rights.
- Shareholder Rights Protection: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights and options to ensure fair treatment.
- Merger Transaction Review: The merger between Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) and Korsana Biosciences, Inc. is expected to result in Cyclerion shareholders owning approximately 1.5% of the combined company, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
- Investor Protection Actions: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, highlighting its crucial role in safeguarding shareholder interests.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) for possibly issuing materially misleading business information, highlighting significant risks to corporate governance and transparency.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely submit its Annual Report for the fiscal year 2025 due to the identification of errors in previously issued financial statements, which may lead to decreased investor confidence and impact stock prices.
- Stock Price Decline: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial health and stability.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket fees, which may attract more affected investors and increase the legal risks faced by the company.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, indicating significant deficiencies in the company's disclosure practices.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, citing the identification of errors in previously issued financial statements as the reason for not filing its Annual Report for the fiscal year ended December 31, 2025, which could undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and management capabilities.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket costs, indicating that the legal risks faced by the company could lead to further financial losses and reputational damage.
See More
Investigation into Multiple Corporate Mergers
- TruBridge Acquisition: TruBridge, Inc. is under investigation regarding its sale to Inventurus Knowledge Solutions, Inc., with shareholders expected to receive $26.25 per share in cash, indicating a strong market expectation for this transaction's positive impact on shareholder value.
- UniFirst Transaction Details: UniFirst Corporation is set to be acquired by Cintas Corporation, with shareholders entitled to $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, which not only enhances UniFirst's market valuation but also provides Cintas with an opportunity to expand its market share.
- Mister Car Wash Acquisition: Mister Car Wash, Inc. is being sold to MCW Parent, LP, with shareholders receiving $7.00 per share in cash, reflecting a trend of consolidation in the car wash industry that may influence future competitive dynamics.
- Barinthus Merger: Barinthus Biotherapeutics plc is merging with Clywedog Therapeutics, Inc., where Barinthus shareholders will receive one share of the new combined company for each share owned, while Clywedog shareholders will receive 4.358932 shares, potentially strengthening both companies' competitive positions in the biotherapeutics sector.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) regarding its sale to Chiesi Group for $27.00 per share, as potential violations of shareholder rights may lead to increased compensation for investors if substantiated.
- Shareholder Rights Protection: The firm is also examining TruBridge, Inc. (NASDAQ:TBRG)'s sale to Inventurus Knowledge Solutions, Inc. for $26.25 per share, encouraging shareholders to contact the firm to understand their legal rights and options, thereby safeguarding their interests.
- Merger Transaction Review: The merger between UniFirst Corporation (NYSE:UNF) and Cintas Corporation, involving $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, may prompt Halper Sadeh LLC to seek increased consideration or other remedies to protect shareholder rights.
- Commitment to Legal Services: Halper Sadeh LLC offers risk-free legal consultations, allowing shareholders to learn about their rights and options without upfront costs, ensuring they receive due compensation in cases of potential securities fraud and corporate misconduct.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ:TBRG) for allegedly issuing materially misleading business information, which may entitle investors to compensation without any out-of-pocket fees.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to file the Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, which could undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns over the company's financial transparency and potential investor losses.
- Legal Action Preparation: Rosen Law Firm is preparing a class action to recover investor losses, emphasizing the importance of selecting qualified counsel with a successful track record to effectively protect investors' rights.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating Organon & Co. (NYSE:OGN) regarding its sale to Sun Pharmaceutical Industries Limited at $14.00 per share, which may involve breaches of shareholder rights.
- Shareholder Rights Protection: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights and options to ensure fair treatment.
- Merger Transaction Review: The merger between Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) and Korsana Biosciences, Inc. is expected to result in Cyclerion shareholders owning approximately 1.5% of the combined company, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
- Investor Protection Actions: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, highlighting its crucial role in safeguarding shareholder interests.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) for possibly issuing materially misleading business information, highlighting significant risks to corporate governance and transparency.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely submit its Annual Report for the fiscal year 2025 due to the identification of errors in previously issued financial statements, which may lead to decreased investor confidence and impact stock prices.
- Stock Price Decline: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial health and stability.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket fees, which may attract more affected investors and increase the legal risks faced by the company.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, indicating significant deficiencies in the company's disclosure practices.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, citing the identification of errors in previously issued financial statements as the reason for not filing its Annual Report for the fiscal year ended December 31, 2025, which could undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and management capabilities.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket costs, indicating that the legal risks faced by the company could lead to further financial losses and reputational damage.
See More
Investigation into Multiple Corporate Mergers
- TruBridge Acquisition: TruBridge, Inc. is under investigation regarding its sale to Inventurus Knowledge Solutions, Inc., with shareholders expected to receive $26.25 per share in cash, indicating a strong market expectation for this transaction's positive impact on shareholder value.
- UniFirst Transaction Details: UniFirst Corporation is set to be acquired by Cintas Corporation, with shareholders entitled to $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, which not only enhances UniFirst's market valuation but also provides Cintas with an opportunity to expand its market share.
- Mister Car Wash Acquisition: Mister Car Wash, Inc. is being sold to MCW Parent, LP, with shareholders receiving $7.00 per share in cash, reflecting a trend of consolidation in the car wash industry that may influence future competitive dynamics.
- Barinthus Merger: Barinthus Biotherapeutics plc is merging with Clywedog Therapeutics, Inc., where Barinthus shareholders will receive one share of the new combined company for each share owned, while Clywedog shareholders will receive 4.358932 shares, potentially strengthening both companies' competitive positions in the biotherapeutics sector.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) regarding its sale to Chiesi Group for $27.00 per share, as potential violations of shareholder rights may lead to increased compensation for investors if substantiated.
- Shareholder Rights Protection: The firm is also examining TruBridge, Inc. (NASDAQ:TBRG)'s sale to Inventurus Knowledge Solutions, Inc. for $26.25 per share, encouraging shareholders to contact the firm to understand their legal rights and options, thereby safeguarding their interests.
- Merger Transaction Review: The merger between UniFirst Corporation (NYSE:UNF) and Cintas Corporation, involving $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, may prompt Halper Sadeh LLC to seek increased consideration or other remedies to protect shareholder rights.
- Commitment to Legal Services: Halper Sadeh LLC offers risk-free legal consultations, allowing shareholders to learn about their rights and options without upfront costs, ensuring they receive due compensation in cases of potential securities fraud and corporate misconduct.
See More
